Direct oral anticoagulants in obese patients with venous thromboembolism: results of an expert consensus panel

RP Rosovsky, E Kline-Rogers, L Lake… - The American Journal of …, 2023 - Elsevier
In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …
被引用次数：9 相关文章

Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus Panel

RP Rosovsky, E Kline-Rogers… - … journal of medicine, 2023 - pubmed.ncbi.nlm.nih.gov
In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …

Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus Panel.

RP Rosovsky, E Kline-Rogers, L Lake… - The American Journal …, 2023 - europepmc.org
In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …

Direct Oral Anticoagulants in Obese Patients with Venous Thromboembolism: Results of an Expert Consensus Panel

RP Rosovsky, E Kline-Rogers, L Lake… - The American Journal …, 2023 - amjmed.com
In clinical practice, direct oral anticoagulants (DOACs) are increasingly used for venous
thromboembolism treatment and prevention. A substantial proportion of patients with venous …